IBDEI3BV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,2180,0)
;;=SOCIAL ENVIRONMENT PROBLEMS^29^164
;;^UTILITY(U,$J,358.4,2181,0)
;;=PARAPHILIC DISORDERS^21^164
;;^UTILITY(U,$J,358.4,2182,0)
;;=PERSONALITY DISORDERS^23^164
;;^UTILITY(U,$J,358.4,2183,0)
;;=CRIME/LEGAL SYSTEM PROBLEMS^6^164
;;^UTILITY(U,$J,358.4,2184,0)
;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^164
;;^UTILITY(U,$J,358.4,2185,0)
;;=RELATIONAL PROBLEMS^25^164
;;^UTILITY(U,$J,358.4,2186,0)
;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^164
;;^UTILITY(U,$J,358.4,2187,0)
;;=SEXUAL DYSFUNCTIONS^27^164
;;^UTILITY(U,$J,358.4,2188,0)
;;=SLEEP-WAKE DISORDERS^28^164
;;^UTILITY(U,$J,358.4,2189,0)
;;=SUBSTANCE DISORDER-ALCOHOL^31^164
;;^UTILITY(U,$J,358.4,2190,0)
;;=SUBSTANCE DISORDER-CANNABIS^33^164
;;^UTILITY(U,$J,358.4,2191,0)
;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^164
;;^UTILITY(U,$J,358.4,2192,0)
;;=SUBSTANCE DISORDER-OPIOID^36^164
;;^UTILITY(U,$J,358.4,2193,0)
;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^164
;;^UTILITY(U,$J,358.4,2194,0)
;;=SUBSTANCE DISORDER-TOBACCO^39^164
;;^UTILITY(U,$J,358.4,2195,0)
;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^164
;;^UTILITY(U,$J,358.4,2196,0)
;;=SUBSTANCE DISORDER-INHALANT^35^164
;;^UTILITY(U,$J,358.4,2197,0)
;;=CLINICAL RESEARCH PROGRAM^4^164
;;^UTILITY(U,$J,358.4,2198,0)
;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^164
;;^UTILITY(U,$J,358.4,2199,0)
;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^164
;;^UTILITY(U,$J,358.4,2200,0)
;;=ELIMINATION DISORDERS^11^164
;;^UTILITY(U,$J,358.4,2201,0)
;;=GAMBLING DISORDER^13^164
;;^UTILITY(U,$J,358.4,2202,0)
;;=OTHER MENTAL DISORDERS^20^164
;;^UTILITY(U,$J,358.4,2203,0)
;;=NEURODEVELOPMENTAL DISORDERS^18^164
;;^UTILITY(U,$J,358.4,2204,0)
;;=SUBSTANCE DISORDER-CAFFEINE^32^164
;;^UTILITY(U,$J,358.4,2205,0)
;;=SUICIDAL IDEATIONS/ATTEMPTS^41^164
;;^UTILITY(U,$J,358.4,2206,0)
;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^164
;;^UTILITY(U,$J,358.4,2207,0)
;;=SUBSTANCE DISORDER-STIMULANTS^38^164
;;^UTILITY(U,$J,358.4,2208,0)
;;=UNDERDOSING OF MEDICATION REGIMEN^43^164
;;^UTILITY(U,$J,358.4,2209,0)
;;=NEW PATIENT^2^165
;;^UTILITY(U,$J,358.4,2210,0)
;;=ESTABLISHED PATIENT^1^165
;;^UTILITY(U,$J,358.4,2211,0)
;;=CONSULTATIONS^3^165
;;^UTILITY(U,$J,358.4,2212,0)
;;=IMMUNIZATIONS^8^166
;;^UTILITY(U,$J,358.4,2213,0)
;;=COUNSELING^4^166
;;^UTILITY(U,$J,358.4,2214,0)
;;=EDUCATION^5^166
;;^UTILITY(U,$J,358.4,2215,0)
;;=EVALUATIONS^6^166
;;^UTILITY(U,$J,358.4,2216,0)
;;=IMMUNIZATION ADMINISTRATION^7^166
;;^UTILITY(U,$J,358.4,2217,0)
;;=TREATMENT PROCEDURES^12^166
;;^UTILITY(U,$J,358.4,2218,0)
;;=INJECTIONS^9^166
;;^UTILITY(U,$J,358.4,2219,0)
;;=PROLONGED CLINICAL STAFF SERVICES^10^166
;;^UTILITY(U,$J,358.4,2220,0)
;;=CARE MGMT FOR BEH HLTH COND^1^166
;;^UTILITY(U,$J,358.4,2221,0)
;;=COGNITIVE ASSESS/CARE PLAN^2^166
;;^UTILITY(U,$J,358.4,2222,0)
;;=COLLABORATIVE CARE MGMT^3^166
;;^UTILITY(U,$J,358.4,2223,0)
;;=THERAPEUTIC INTVN^11^166
;;^UTILITY(U,$J,358.4,2224,0)
;;=TBI SCREENING^1^167
;;^UTILITY(U,$J,358.4,2225,0)
;;=MENTAL HEALTH^4^167
;;^UTILITY(U,$J,358.4,2226,0)
;;=NEUROLOGY^5^167
;;^UTILITY(U,$J,358.4,2227,0)
;;=HEADACHES^2^167
;;^UTILITY(U,$J,358.4,2228,0)
;;=HISTORY OF ILLNESS^3^167
;;^UTILITY(U,$J,358.4,2229,0)
;;=SIGNS, SYMPTOMS, CONDITIONS^6^167
;;^UTILITY(U,$J,358.4,2230,0)
;;=CAUSES OF INJURY (SECONDARY DX ONLY)^8^167
;;^UTILITY(U,$J,358.4,2231,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^7^167
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3BV 3779 printed Apr 09, 2024@22:01:03 Page 2
IBDEI3BV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,2180,0)
+2 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^164
+3 ;;^UTILITY(U,$J,358.4,2181,0)
+4 ;;=PARAPHILIC DISORDERS^21^164
+5 ;;^UTILITY(U,$J,358.4,2182,0)
+6 ;;=PERSONALITY DISORDERS^23^164
+7 ;;^UTILITY(U,$J,358.4,2183,0)
+8 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^164
+9 ;;^UTILITY(U,$J,358.4,2184,0)
+10 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^164
+11 ;;^UTILITY(U,$J,358.4,2185,0)
+12 ;;=RELATIONAL PROBLEMS^25^164
+13 ;;^UTILITY(U,$J,358.4,2186,0)
+14 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^164
+15 ;;^UTILITY(U,$J,358.4,2187,0)
+16 ;;=SEXUAL DYSFUNCTIONS^27^164
+17 ;;^UTILITY(U,$J,358.4,2188,0)
+18 ;;=SLEEP-WAKE DISORDERS^28^164
+19 ;;^UTILITY(U,$J,358.4,2189,0)
+20 ;;=SUBSTANCE DISORDER-ALCOHOL^31^164
+21 ;;^UTILITY(U,$J,358.4,2190,0)
+22 ;;=SUBSTANCE DISORDER-CANNABIS^33^164
+23 ;;^UTILITY(U,$J,358.4,2191,0)
+24 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^164
+25 ;;^UTILITY(U,$J,358.4,2192,0)
+26 ;;=SUBSTANCE DISORDER-OPIOID^36^164
+27 ;;^UTILITY(U,$J,358.4,2193,0)
+28 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^164
+29 ;;^UTILITY(U,$J,358.4,2194,0)
+30 ;;=SUBSTANCE DISORDER-TOBACCO^39^164
+31 ;;^UTILITY(U,$J,358.4,2195,0)
+32 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^164
+33 ;;^UTILITY(U,$J,358.4,2196,0)
+34 ;;=SUBSTANCE DISORDER-INHALANT^35^164
+35 ;;^UTILITY(U,$J,358.4,2197,0)
+36 ;;=CLINICAL RESEARCH PROGRAM^4^164
+37 ;;^UTILITY(U,$J,358.4,2198,0)
+38 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^164
+39 ;;^UTILITY(U,$J,358.4,2199,0)
+40 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^164
+41 ;;^UTILITY(U,$J,358.4,2200,0)
+42 ;;=ELIMINATION DISORDERS^11^164
+43 ;;^UTILITY(U,$J,358.4,2201,0)
+44 ;;=GAMBLING DISORDER^13^164
+45 ;;^UTILITY(U,$J,358.4,2202,0)
+46 ;;=OTHER MENTAL DISORDERS^20^164
+47 ;;^UTILITY(U,$J,358.4,2203,0)
+48 ;;=NEURODEVELOPMENTAL DISORDERS^18^164
+49 ;;^UTILITY(U,$J,358.4,2204,0)
+50 ;;=SUBSTANCE DISORDER-CAFFEINE^32^164
+51 ;;^UTILITY(U,$J,358.4,2205,0)
+52 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^164
+53 ;;^UTILITY(U,$J,358.4,2206,0)
+54 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^164
+55 ;;^UTILITY(U,$J,358.4,2207,0)
+56 ;;=SUBSTANCE DISORDER-STIMULANTS^38^164
+57 ;;^UTILITY(U,$J,358.4,2208,0)
+58 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^164
+59 ;;^UTILITY(U,$J,358.4,2209,0)
+60 ;;=NEW PATIENT^2^165
+61 ;;^UTILITY(U,$J,358.4,2210,0)
+62 ;;=ESTABLISHED PATIENT^1^165
+63 ;;^UTILITY(U,$J,358.4,2211,0)
+64 ;;=CONSULTATIONS^3^165
+65 ;;^UTILITY(U,$J,358.4,2212,0)
+66 ;;=IMMUNIZATIONS^8^166
+67 ;;^UTILITY(U,$J,358.4,2213,0)
+68 ;;=COUNSELING^4^166
+69 ;;^UTILITY(U,$J,358.4,2214,0)
+70 ;;=EDUCATION^5^166
+71 ;;^UTILITY(U,$J,358.4,2215,0)
+72 ;;=EVALUATIONS^6^166
+73 ;;^UTILITY(U,$J,358.4,2216,0)
+74 ;;=IMMUNIZATION ADMINISTRATION^7^166
+75 ;;^UTILITY(U,$J,358.4,2217,0)
+76 ;;=TREATMENT PROCEDURES^12^166
+77 ;;^UTILITY(U,$J,358.4,2218,0)
+78 ;;=INJECTIONS^9^166
+79 ;;^UTILITY(U,$J,358.4,2219,0)
+80 ;;=PROLONGED CLINICAL STAFF SERVICES^10^166
+81 ;;^UTILITY(U,$J,358.4,2220,0)
+82 ;;=CARE MGMT FOR BEH HLTH COND^1^166
+83 ;;^UTILITY(U,$J,358.4,2221,0)
+84 ;;=COGNITIVE ASSESS/CARE PLAN^2^166
+85 ;;^UTILITY(U,$J,358.4,2222,0)
+86 ;;=COLLABORATIVE CARE MGMT^3^166
+87 ;;^UTILITY(U,$J,358.4,2223,0)
+88 ;;=THERAPEUTIC INTVN^11^166
+89 ;;^UTILITY(U,$J,358.4,2224,0)
+90 ;;=TBI SCREENING^1^167
+91 ;;^UTILITY(U,$J,358.4,2225,0)
+92 ;;=MENTAL HEALTH^4^167
+93 ;;^UTILITY(U,$J,358.4,2226,0)
+94 ;;=NEUROLOGY^5^167
+95 ;;^UTILITY(U,$J,358.4,2227,0)
+96 ;;=HEADACHES^2^167
+97 ;;^UTILITY(U,$J,358.4,2228,0)
+98 ;;=HISTORY OF ILLNESS^3^167
+99 ;;^UTILITY(U,$J,358.4,2229,0)
+100 ;;=SIGNS, SYMPTOMS, CONDITIONS^6^167
+101 ;;^UTILITY(U,$J,358.4,2230,0)
+102 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^8^167
+103 ;;^UTILITY(U,$J,358.4,2231,0)
+104 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^167
